Building on their existing collaboration, the companies have signed a new agreement to focus on lead optimization of drug candidates identified by Variational AI’s Enki™ generative AI platform and ...
Amazon S3 on MSN
The surprising physics behind smarter artificial intelligence
What if AI had its own periodic table? Scientists at Emory University have just unveiled a groundbreaking mathematical ...
Hosted on MSN
Merck & Co., Inc. (MRK) Partners with Variational AI to leverage AI in Enhancing Drug Development
Merck & Co. Inc., (NYSE:MRK) is one of the best conservative stocks to buy now. On September 23, the company confirmed a strategic collaboration with Variational AI to leverage its Enki Platform in ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, today announced a project with Merck Research ...
Merck & Co. has doubled down on its partnership with Variational AI, striking a deal worth up to $349 million to collaborate on small molecule candidates against two targets. Variational disclosed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback